The MYC, KRAS, TGFB2, PIK3R3, CDKN1A, FOS, and GADD45B DEmRNAs were regarded as the most important DEmRNAs involved in the mechanism by which GA-Me treats CRC, as their dysregulation might result in the progression of CRC. This evidence concerns the gene FOS and colorectal carcinoma.